Created in 1949, by the late Founder Mr. Abderrahim Bennis, LAPROPHAN is the pioneering Company of the Pharmaceutical Industry and the undisputed leader in Morocco.
Proud of our history and ambitious towards our future, our mission is to participate actively in the evolution of the Moroccan pharmaceutical sector, thanks to our commitment to develop innovative products with high added value and accessible
to our fellow citizens.
LAPROPHAN medicines enjoy a high reputation, result of a constant search for innovation and continuous improvement of quality standards, enabling it to be a major player in the field of healthcare.
LAPROPHAN is the first Moroccan laboratory to have an R & D center and to be awarded five (5) national and international patent laws of invention and innovation.
We offer patients and healthcare professionals a wide range of products (more than 400 specialties) covering a large number of therapeutic classes, both under our own brand names and under license of other international partner laboratories, like:
PFIZER, NOVARTIS, BMS, BAXTER, MEDA, P & G, SANOFI, DANONE, NOVO NORDISK, MERCK, MUNDIPHARMA and ASTELLAS.
We are internationally renowned for our positioning as one of the leading healthcare providers in several countries; our vision is to promote South-South cooperation through a variety of partnerships:
- Export to not less than 30 countries (MENA, Africa).
Our strengths and our commitments have guaranteed us a national and international recognition which was illustrated in 2016 by our participation in the COP 22 of MARRAKECH (LAPROPHAN having been an official partner).